UAE moves to secure round-the-clock satellite view of Earth

gulfnews.com Sep 23, 2026

UAE moves to secure round-the-clock satellite view of Earth

Curated by Shubham · TechCapsules · Sep 23, 2026

AI-summarised brief · reviewed before publication

The United Arab Emirates is advancing its own round‑the‑clock Earth observation capability through Space42’s Foresight synthetic‑aperture radar (SAR) constellation. The five‑satellite system, based in Abu Dhabi, can acquire geospatial data day and night, regardless of cloud, haze or dust, delivering decision‑grade intelligence to government and corporate users. CEO Christos Kolimenakis of ICEYE UAE highlighted the technology’s ability to monitor any point at any time, while Space42 senior manager Abdullah Sharif said a second batch of satellites will launch in 2027 to complete the constellation’s maturity. Faster revisit times—shrinking from days to hours—enable rapid detection of ground changes, supporting quicker, more confident decision‑making. The initiative is framed as a sovereignty effort, reducing reliance on foreign imagery providers and fostering a domestic space‑tech ecosystem.

💡 Why It Matters

· By controlling its own SAR data stream, the UAE gains strategic autonomy in monitoring critical infrastructure and security threats, while cultivating a homegrown space industry.

Capsules Space

Read full article on gulfnews.com

Spacetech’s Next Big Test, Weekly Funding Rundown & More

The Indian spacetech sector, having secured $253 million in funding this year—double last year’s total—faces a critical test of commercial viability despite record capital inflows, regulatory momentum, and technical milestones. Skyroot’s recent unicorn status and Pixxel’s $100 million round, the largest in the sector, underscore investor enthusiasm. Yet concerns over inflated valuations, hardware risks, and a nascent market for launch infrastructure and earth observation persist. Investors now demand clear use cases, defensible differentiation, and tangible metrics, signaling a shift toward consolidation and potential public‑market exits.

💡 The sector’s rapid capital surge is reshaping India’s high‑tech landscape, positioning it as a contender in global space commerce. However, the pressure to translate engineering wins into sustainable revenue models could redefine investment strategies and industry structure.

spacenews.com · Sep 21

Commercial Space Federation (CSF) Welcomes Two New Members

The Commercial Space Federation (CSF) announced the addition of ORBITInsure and Renaissance Strategic Advisors (RSA) as new members on September 21, 2026. ORBITInsure joins as a Space Supply Chain member, offering data‑driven risk intelligence for space insurance. RSA becomes an Associate Member and participates in the Space Supply Chain Council and State and Local Council, bringing strategy and M&A expertise to aerospace, defense, and government sectors. Both firms aim to strengthen the commercial space ecosystem through enhanced risk management and strategic insight.

💡 By integrating advanced risk analytics and strategic advisory services, CSF expands its capacity to support emerging and established space ventures, positioning the U.S. commercial space industry for more resilient growth.

247wallst.com · Sep 21

Elon Musk Predicts Starlink Satellites Could Rewrite the Rules of Global Connectivity

Elon Musk announced on SpaceX’s August 4 earnings call that the next‑generation Starlink V3 satellites will deliver about 10 terabits per second bidirectionally, with potential to reach over 100 Tbps. Each satellite will carry a 250‑kW power system and a custom Nvidia Vera Rubin NVL72 computer. Musk projected that within ten years Starlink could handle the majority of global internet traffic, especially as AI and robotics demand increases. SpaceX plans to launch roughly an order of magnitude more V3 satellites, aiming for a two‑order‑of‑magnitude bandwidth boost and a 10‑fold revenue rise.

💡 The leap in satellite bandwidth could shift the balance of global connectivity, enabling high‑speed internet in underserved regions and supporting the data needs of emerging AI and robotics ecosystems.

inc42.com · Sep 20

India’s Spacetech Gold Rush Is Here, But What’s Making Investors Jumpy?

India’s spacetech sector has entered a commercialisation phase, raising $252.9 million in 2026, nearly double the 2025 total. Skyroot Aerospace became the first Indian spacetech unicorn after a $60 million round and successfully launched its Vikram‑1 rocket, now pursuing a $200 million follow‑up. Pixxel, backed by Temasek, secured a record $100 million Series C, the largest single funding round for an Indian space company. Government funds—₹1,600 cr from IN‑SPACe’s Antariksh VC and ₹834 cr from the RDI fund—backed early‑stage ventures. Startups now face heightened scrutiny on commercial viability, demand, and scalability.

💡 The surge in capital and policy support signals a shift from experimental to revenue‑driven space ventures, positioning India as a competitive player in global space markets.

forumias.com · Sep 20

A Homegrown Innovation Ecosystem is Taking Root

India is transitioning from a technology importer to a creator, with public research institutions, corporate R&D, and deep‑tech startups driving growth in semiconductors, communications, space, and healthcare. Patent filings have risen, and indigenous products are emerging, yet R&D spending remains low and commercialisation weak. Talent shortages and limited research capacity hinder full market penetration. Government policy pushes for innovation, but stronger industry‑research links, technology transfer mechanisms, and support for frontier technologies are needed to close gaps and build a technology‑driven economy.

💡 The shift signals India’s potential to become a global tech hub, reshaping its economic trajectory and reducing dependence on foreign imports.

taipeitimes.com · Sep 20

Drugmakers eye next phase of space research

As the International Space Station approaches retirement, major drugmakers are preparing to conduct commercial pharmaceutical research and manufacturing in low Earth orbit. Executives from pharmaceutical, biotechnology, and space firms are collaborating with regulators to establish guidelines for space-based medicine production, aiming to prove it can be reliable and cost‑effective. Companies such as LambdaVision, Auxilium Biotechnologies, and Merck have already used the ISS to develop retinal implants, bioprinted tissues, and a subcutaneous cancer therapy. The shift toward next‑generation commercial stations—like Starlab, Vast, and Axiom—promises scalable, automated production environments that could reduce turnaround times and lower costs.

💡 The move to orbital manufacturing could unlock new drug development pathways that are impossible on Earth, offering faster, more precise production of complex biologics and potentially transforming global pharmaceutical supply chains.